18F-FDG positron emission tomography/computed tomography in infective endocarditis

J Nucl Cardiol. 2017 Feb;24(1):195-206. doi: 10.1007/s12350-015-0325-y. Epub 2015 Dec 9.

Abstract

Background: The diagnosis of infective endocarditis (IE), especially the diagnosis of prosthetic valve endocarditis (PVE) is challenging since echocardiographic findings are often scarce in the early phase of the disease. We studied the use of 2-[18F]fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) in IE.

Methods: Sixteen patients with suspected PVE and 7 patients with NVE underwent visual evaluation of 18F-FDG-PET/CT. 18F-FDG uptake was measured also semiquantitatively as maximum standardized uptake value (SUVmax) and target-to-background ratio (TBR). The modified Duke criteria were used as a reference.

Results: There was strong, focal 18F-FDG uptake in the area of the affected valve in all 6 cases of definite PVE, in 3 of 5 possible PVE cases, and in 2 of 5 rejected cases. In all patients with definite PVE, SUVmax of the affected valve was higher than 4 and TBR higher than 1.8. In contrast to PVE, only 1 of 7 patients with NVE had uptake of 18F-FDG by PET/CT in the valve area. Embolic infectious foci were detected in 58% of the patients with definite IE.

Conclusions: 18F-FDG-PET/CT appears to be a sensitive method for the detection of paravalvular infection associated with PVE. Instead, the sensitivity of PET/CT is limited in NVE.

Keywords: 18F-fluorodeoxyglucose; Infective endocarditis; echocardiography; positron emission tomography; prosthetic valve endocarditis.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Endocarditis / diagnostic imaging*
  • Endocarditis / etiology
  • Female
  • Fluorodeoxyglucose F18*
  • Heart Valve Diseases / diagnostic imaging*
  • Heart Valve Diseases / etiology
  • Heart Valve Prosthesis / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Positron Emission Tomography Computed Tomography / methods*
  • Prosthesis-Related Infections / diagnostic imaging*
  • Prosthesis-Related Infections / etiology
  • Radiopharmaceuticals
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18